This paper is in the following e-collection/theme issue:

Corrigenda and Addenda (44)

Published on in Vol 8, No 4 (2020): April

Correction: A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial

Correction: A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial

Correction: A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial

Authors of this article:

Zhilian Huang1, 2 Author Orcid Image ;   Eberta Tan3 Author Orcid Image ;   Elaine Lum1, 4, 5 Author Orcid Image ;   Peter Sloot6, 7, 8 Author Orcid Image ;   Bernhard Otto Boehm9, 10 Author Orcid Image ;   Josip Car1 Author Orcid Image
Article Authors Cited by (2) Tweetations (2) Metrics

    Corrigenda and Addenda

    1Centre for Population Health Sciences, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore

    2NTU Institute for Health Technologies, Interdisciplinary Graduate School, Nanyang Technological University, Singapore, Singapore

    3Department of Endocrinology, Changi General Hospital, Singapore, Singapore

    4Institute of Health and Biomedical Innovation, Queensland University of Technology, Queensland, Australia

    5School of Clinical Sciences, Faculty of Health, Queensland University of Technology, Queensland, Australia

    6Complexity Institute, Nanyang Technological University, Singapore, Singapore

    7Institute for Advanced Science, University of Amsterdam, Amsterdam, Netherlands

    8ITMO University, Saint Petersburg, Russian Federation

    9Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore

    10Department of Endocrinology, Tan Tock Seng Hospital, Singapore, Singapore

    Corresponding Author:

    Zhilian Huang, MPH

    Centre for Population Health Sciences

    Lee Kong Chian School of Medicine

    Nanyang Technological University

    Clinical Sciences Building, Level 18

    11 Mandalay Road

    Singapore, 308232

    Singapore

    Phone: 65 65141221

    Email: zhuang014@e.ntu.edu.sg



    The authors of “A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial” (JMIR Mhealth Uhealth 2019;7(9):e14914) noticed an error in the Results section of their published article. Under the “Adherence to Trial Participation” subsection of the Results section, the following sentence:

    Eight participants had 100% adherence for the first 2 weeks of the intervention, which was decreased to 4% by the third week of the intervention.

    Has been changed to:

    Eight participants had 100% adherence for the first 2 weeks of the intervention, which was decreased to four participants by the third week of the intervention.

    This change does not affect any of the data presented in the Results section of the paper.

    The correction will appear in the online version of the paper on the JMIR website on April 29, 2020, together with the publication of this correction notice. Because this was made after submission to PubMed, PubMed Central, and other full-text repositories, the corrected article has also been resubmitted to those repositories.

    This is a non–peer-reviewed article. submitted 25.02.20; accepted 25.02.20; published 29.04.20.

    Copyright

    ©Zhilian Huang, Eberta Tan, Elaine Lum, Peter Sloot, Bernhard Otto Boehm, Josip Car. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 29.04.2020.

    This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mHealth and uHealth, is properly cited. The complete bibliographic information, a link to the original publication on http://mhealth.jmir.org/, as well as this copyright and license information must be included.